Fashion Fair Exited Sephora. Now It’s Playing A Longer Game.
Not every throwback has a triumphant comeback, at least not right away. When former Johnson Publishing executives Desirée…
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026
New Spherix Global Insights research finds no clear standard of care beyond second line, creating an opportunity for…